Prof. Rejko Krüger, FNR Pearl Chair: connecting fundamental research and clinical care

Prof. Rejko Krüger is a Professor for Clinical and Experimental Neuroscience at the University of Luxembourg, the Director of Transversal Translational Medicine at the Luxembourg Institute of Health (LIH), a neurologist at the Centre Hospitalier de Luxembourg (CHL) and holds an FNR PEARL Chair. He works closely with researchers, clinicians and patients to advance Parkinson’s disease research in Luxembourg. Since June 2019, he links between the LIH and the University’s Luxembourg Centre for Systems Biomedicine (LCSB) to contribute to personalised medicine by implementing translational research programmes involving partners from different fields within a joint scientific strategy.

Rejko Krüger integrates expertise in fundamental research on neurodegeneration and clinical research as the coordinator of the National Centre of Excellence in Research on Parkinson’s disease funded by the FNR, the research programme that contributed to the the new Neurodegenerative Diseases Competence Network “ParkinsonNet Luxembourg”. Thanks to this large-scale research programme, involving many participants from Luxembourg and the Greater Region, with and without Parkinson’s disease, Luxembourg researchers have acquired new knowledge that will help distinguish between the different forms of the disease, diagnose them more accurately and implement precision medicine strategies.

Find out more about the research on the path to Medicine 2.0 and the concrete work of Prof. Krüger and his team with Parkinson’s patients in Luxembourg in this video.

Dr Guy Fagherazzi: CoLive Voice – why your voice can help to improve healthcare

Dr Guy Fagherazzi is the Director of the Department of Precision Health at the Luxembourg Institute of Health (LIH), which is composed of 9 research units and where he leads the research activity in public health and epidemiology. He is also the Head of the Deep Digital Phenotyping Research Unit at LIH. He is a senior research scientist in Digital Epidemiology with strong expertise in the analysis of large population-based studies using Artificial Intelligence methods. 

In this podcast, Dr Fagherazzi presents CoLive Voice, an international digital health study led by the Luxembourg Institute of Health. This innovative study aims to improve diagnosis and monitoring of various chronic diseases, such as cancer, diabetes and COVID-19, by evaluating voice features.  The researchers need many participants worldwide, speaking different languages and being either healthy or living with a chronic disease.

Dr Guy Berchem: Research is advancing, so is your treatment

Dr Guy Berchem is an experienced Medical Oncologist with a PhD focused in Cancer Immunology from Université Paris Sud (Paris XI) and a demonstrated history of working in the hospital fundamental and clinical research. Guy Berchem is Medical Director of the Luxembourg Institute of Health (LIH) and Professor of Medical Oncology at the University of Luxembourg.

In this video, Dr Berchem presents immunotherapy, a novel approach to combat cancer in which clinicians use drugs to encourage the patient’s immune system itself to attack tumours. Learn more about how the Luxembourg Institute of Health (LIH) works alongside the Centre Hospitalier de Luxembourg to support your cancer treatment.

Prof. Jochen Klucken, FNR Pearl Chair of Digital Medicine: How technology can make the life of patients and healthcare providers easier

Prof. Jochen Klucken is a neurologist and neuroscientist, the FNR-PEARL Chair of Digital Medicine (LCSB, CHL) and the head of the Digital Medicine group at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg. Prof. Klucken’s research focuses on personalised digital healthcare solutions and the medico-socio-economic benefit of new digital medical devices and services. Prof. Klucken is also co-leading as a rapporteur the EU taskforce for harmonised evaluation of digital medical devices.

Personalised digital healthcare solutions such as apps or sensors will help to monitor and accompany the patients and provide clinical decision support for healthcare providers. Using the Parkinson’s disease as a model, the Digital Medicine group at the LCSB focuses on developing digital tools and services, addresses the questions of medical benefit, procedural changes necessary for the implementation of digital tools, as well as social acceptance of digital healthcare services.

Learn more about the mission of the Chair of Digital Medicine and how technology can make the life of patients and healthcare providers easier in this video.

Dr India Pinker: “Luxembourg is a place for translational research by nature”

Dr India Pinker is a postdoctoral fellow at the Ageing, Cancer and Disparities Research Unit (ACADI) at the Luxembourg Institute of Health (LIH). Specialised in health psychology, her research work aims at understanding the treatment decision-making process for treatment of cancer in older adults in Luxembourg. Read here why she chose Luxembourg for her scientific career.

Latest news